Cart
sales@molnova.com
GPDA
CAS No. 65096-46-0
GPDA( GPN | Glycylproline p-nitroanilide tosylate )
Catalog No. M24662 CAS No. 65096-46-0
GPDA is a substrate of X-Prolyl dipeptidyl-aminopeptidase in the enzyme assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 32 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 55 | In Stock |
|
| 100MG | 86 | In Stock |
|
| 200MG | 126 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGPDA
-
NoteResearch use only, not for human use.
-
Brief DescriptionGPDA is a substrate of X-Prolyl dipeptidyl-aminopeptidase in the enzyme assay.
-
DescriptionGPDA is a substrate of X-Prolyl dipeptidyl-aminopeptidase in the enzyme assay.
-
In Vitro——
-
In Vivo——
-
SynonymsGPN | Glycylproline p-nitroanilide tosylate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65096-46-0
-
Formula Weight464.49
-
Molecular FormulaC20H24N4O7S
-
Purity>98% (HPLC)
-
SolubilityDMSO:98 mg/mL (210.98 mM; Need ultrasonic)
-
SMILESO=C([C@H](CCC1)N1C(CN)=O)NC2=CC=C([N+]([O-])=O)C=C2.O=S(C3=CC=C(C)C=C3)(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hino M, et al. X-Prolyl dipeptidyl-aminopeptidase activity, with X-proline p-nitroanilides as substrates, in normal and pathological human sera. Clin Chem. 1976 Aug;22(8):1256-61.
molnova catalog
related products
-
Substance P 1-7
Substance P 1-7 is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP)with anti-inflammatory anti-nociceptive and anti-hyperalgesic effects.
-
Fenchlorphos
Ronnel is a Filipino politician, entrepreneur, and businessman and a former councilor and currently serving as Mayor of General Santos.
-
PF-05231023
PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist. It is also suitable for development as a potential treatment for T2DM. PF-05231023 is a analog of long-acting fibroblast growth factor 21.
